Acquisition growth InVita Health is rapidly expanding through strategic acquisitions, including MAK-SYSTEM International Group and IT Synergistics, broadening end-to-end blood management capabilities and global reach. This suggests opportunities to upsell integrated platforms and cross-sell new modules to newly combined customers.

Comprehensive suite expansion Recent launches such as iReferral software and advanced therapy capabilities within HemaConnect 2.5 indicate a push into interoperability and advanced treatment workflows. Target prospects should be approached with bundled solutions that address donor scheduling, logistics, lab compliance, and therapy support.

Compliance and governance ISO 13485 alignment and cloud-based AWS/GovCloud infrastructure position InVita as a compliant partner for regulated blood and biologics environments. Sales pitches can emphasize risk mitigation, audit readiness, and data integrity for centers requiring strict quality management and traceability.

Strategic partnerships Collaborations with Gulf Coast Blood, Giveblood, and regional OPOs like MORA highlight a networked approach to donor management and transplant workflows. There are opportunities to expand through alliance-based deals with other centers, hospitals, and procurement organizations seeking integrated software ecosystems.

Global deployment and scale With international expansion evidenced by MAK-SYSTEM integration and global announcements, InVita is targeting worldwide adoption. Prospects include multinational blood centers and hospital systems seeking scalable, standardized software across multiple sites and geographies.